Oxaliplatin-induced neurotoxicity and the development of neuropathy

Arun V Krishnan1, David Goldstein, Michael Friedlander

  • 1Institute of Neurological Sciences, Prince of Wales Hospital, Sydney, NSW, Australia.

Muscle & Nerve
|May 10, 2005
PubMed

Insights

Oxaliplatin chemotherapy can cause persistent nerve damage (neurotoxicity), affecting sensory nerves. This study found nerve excitability changes, suggesting voltage-gated sodium channel dysfunction, even after symptoms improve.

Area of Science:

  • Neuroscience
  • Clinical Neurology
  • Pharmacology

Background:

  • Oxaliplatin is a platinum-based chemotherapy agent used to treat colorectal cancer.
  • Oxaliplatin-induced neurotoxicity is a common and dose-limiting side effect, but its underlying mechanisms are not fully understood.
  • In vitro studies suggest voltage-gated sodium channels play a role in this neurotoxicity.

Purpose of the Study:

  • To investigate the pathophysiology of oxaliplatin-induced neurotoxicity in patients.
  • To correlate clinical symptoms with objective nerve function measures.
  • To explore the role of voltage-gated sodium channels in persistent neurotoxicity.

Main Methods:

  • Clinical assessment of neuropathic symptoms in 16 patients post-oxaliplatin therapy.
  • Nerve conduction studies (NCS) to evaluate sensory and motor nerve function.
  • Nerve excitability studies to assess axonal properties and refractoriness.
  • Longitudinal follow-up at 12 months.

Main Results:

  • 50% of patients experienced persistent chronic neuropathic symptoms.
  • Symptomatic patients showed significantly reduced sensory potentials on NCS, while motor studies were normal.
  • Nerve excitability studies revealed high-threshold axons and significantly increased refractoriness in symptomatic patients.
  • Cumulative oxaliplatin dose predicted neuropathy, with lower single-infusion doses potentially minimizing long-term effects.

Conclusions:

  • Oxaliplatin-induced neurotoxicity involves persistent abnormalities in sensory nerve conduction and excitability, even when positive sensory symptoms improve.
  • Increased refractoriness and high-threshold axons suggest dysfunction of voltage-gated transient sodium channels.
  • These findings support in vitro data implicating sodium channel dysfunction in oxaliplatin neurotoxicity pathophysiology.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...